OTCMKTS:CLABF Core One Labs (CLABF) Stock Price, News & Analysis → Crypto Market Preps For Trillions Worth of Inflows! (From Crypto 101 Media) (Ad) Free CLABF Stock Alerts $0.16 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$0.16▼$0.1850-Day Range$0.15▼$0.2252-Week Range$0.12▼$0.50Volume25,862 shsAverage Volume4,983 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get Core One Labs alerts: Email Address Ad DTIthe most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.And you can see how it works for FREE when you Click Here About Core One Labs Stock (OTCMKTS:CLABF)Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and operates medical clinics, as well as engages in micro cultivation. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.Read More CLABF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLABF Stock News HeadlinesMarch 22, 2024 | americanbankingnews.comCore One Labs (OTCMKTS:CLABF) Stock Price Down 1.3%February 23, 2024 | finance.yahoo.comCore One Labs Inc. (CLABF)March 29, 2024 | DTI (Ad)the most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.February 1, 2024 | morningstar.comCore One Labs IncDecember 8, 2023 | finance.yahoo.comCore One Labs Inc. Announces Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin, Facilitating Entry into the International MarketDecember 1, 2023 | finance.yahoo.comCore One Labs’ Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer’s and Parkinson’s, Showing Potential to Outperform Current Treatment MethodsOctober 9, 2023 | msn.comHalliburton And Core Laboratories Collaborate To Accelerate Digital Rock Data SolutionsSeptember 1, 2023 | msn.comNew KU core laboratory enhances research for infectious diseaseMarch 29, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…August 18, 2023 | finanznachrichten.deÜbersicht Suchergebnisse zum Thema CORE ONE LABS INCAugust 16, 2023 | msn.comCore Laboratories: 'Spooked The Herd' In June, Things Might Be Looking UpAugust 4, 2023 | finance.yahoo.comCore One's Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer’s and Parkinson's DiseaseAugust 1, 2023 | finance.yahoo.comCore One Labs', Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom BiomassJuly 28, 2023 | benzinga.comCore One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer's and Parkinson's DiseaseJuly 28, 2023 | finance.yahoo.comCore One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer’s and Parkinson’s DiseaseJuly 24, 2023 | benzinga.comCore One Labs Enters Into LOI For First Sale Of Its Psychedelic CompoundsJuly 21, 2023 | finanznachrichten.deCore One Labs Inc.: Core One Labs Enters into Letter of Intent for First Sale of Its Psychedelic CompoundsJuly 21, 2023 | finance.yahoo.comCore One Labs Enters into Letter of Intent for First Sale of Its Psychedelic CompoundsJuly 11, 2023 | finance.yahoo.comCore One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic PsilocybinJuly 7, 2023 | finanznachrichten.deCore One Labs Inc.: Core One's Vocan Files International Patent for its Breakthrough Proprietary Biosynthetic Psilocybin Production MethodJuly 7, 2023 | finance.yahoo.comCore One's Vocan Files International Patent for its Breakthrough Proprietary Biosynthetic Psilocybin Production MethodMay 5, 2023 | finanznachrichten.deCore One Labs Inc.: Core One in Talks with Multiple Companies to Supply PsilocybinMay 1, 2023 | finance.yahoo.comCore One Labs' GMP Drug Takes Further Steps Toward Commercialization: Initiating Development of Psychedelic Prodrugs with Long-established Compounding PharmacyApril 24, 2023 | msn.comCore One's Awakened Lays The Groundwork For The Large-Scale Production Of Psychedelic Compounds With Synthetic Production Of PsilocinApril 21, 2023 | finanznachrichten.deCore One Labs Inc.: Core One's Awakened Completes Successful Synthetic Production of Psilocin in its GMP Certified Manufacturing FacilityApril 21, 2023 | finance.yahoo.comCore One's Awakened Completes Successful Synthetic Production of Psilocin in its GMP Certified Manufacturing FacilityMarch 31, 2023 | msn.comInternet Crying Over Why Black Lab's Paw Prints Are Imprinted in ConcreteSee More Headlines Receive CLABF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core One Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:CLABF CUSIPN/A CIK1640152 Webcore1labs.com Phone(866) 452-6731FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Joel Shacker (Age 33)CEO & Director Comp: $179.39kMr. Geoffrey Balderson (Age 46)CFO, Secretary & Director Comp: $30.24kDr. Santiago FerroChief Medical Officer & DirectorMr. Brad Paul Eckenweiler (Age 70)Founder & Advisor Mr. Jan Burian Ph.D.Chief Technical OfficerDr. Elizabeth MatthewsHead of Scientific & Regulatory AffairsMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors CLABF Stock Analysis - Frequently Asked Questions How have CLABF shares performed in 2024? Core One Labs' stock was trading at $0.2389 at the beginning of the year. Since then, CLABF shares have decreased by 33.0% and is now trading at $0.16. View the best growth stocks for 2024 here. Are investors shorting Core One Labs? Core One Labs saw a decline in short interest in February. As of February 15th, there was short interest totaling 2,000 shares, a decline of 81.8% from the January 31st total of 11,000 shares. Based on an average trading volume of 9,200 shares, the short-interest ratio is currently 0.2 days. View Core One Labs' Short Interest. How do I buy shares of Core One Labs? Shares of CLABF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CLABF) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core One Labs Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.